Viloxazine
Qelbree (viloxazine) is a small molecule pharmaceutical. Viloxazine was first approved as Qelbree on 2021-04-02. It is used to treat depression in the USA. Qelbree's patent is valid until 2033-02-07 (FDA).
Trade Name | Qelbree |
---|---|
Common Name | Viloxazine |
Indication | depression |
Drug Class | Antidepressant; Norepinephrine reuptake inhibitor |